- Advertise
- Contact Us
- Editorial Info
- Contribute
- Terms and Conditions
- Privacy Policy
- Do not sell my Personal Information
© 2022 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
COVID-19
The Rheumatology Network COVID-19 clinical focus page provides information on the latest COVID-19 news, study and clinical trial findings, and clinical guideline updates for the treatment of COVID-19. We feature expert interviews with leading physicians and investigators, articles, videos, podcasts, and breaking FDA approvals for COVID-19 drugs.
COVID-19 Booster Improves Humoral, Cellular Immunogenicity in SLE, RA
July 29, 2022
Although a third dose of mRNA vaccine significantly increased antireceptor-binding domain (RBD) titer in a previous study, clinical factors associated with the immunogenicity in immunosuppressed populations have not been adequately studied.
COVID-19 Negatively Impacted Emotional and Social Wellbeing in Patients with RA
July 28, 2022
The top 5 themes identified surrounded fear as the dominant emotion, social connections and work, physical health, self-identity, and self-management as a way of coping.
Obesity Increases Risk of COVID-19 Hospitalization in Juvenile Patients
July 21, 2022
“Understanding the impact of COVID-19 infection on children and young people with RMDs is important to inform national protection, education (such as school attendance), and vaccination guidance."
Autoimmune Inflammatory Disease Increases Risk of COVID-19 Hospitalization
July 15, 2022
"COVID-19 raises special concerns regarding its course and outcome among patients with IMIDs," investigators stated.
Emotional Stressors May Trigger PFAPA Attacks in Pediatric Patients
July 14, 2022
“These results show that emotional distress is associated with higher frequency of PFAPA attacks, thus may be considered as an environmental trigger for PFAPA attack," investigators stated.
COVID-19 Booster Linked to Lower Infection Rates in Patients with SLE
July 13, 2022
Additional doses improved seroconversion and most vaccinated patients with lupus experienced a generally mild course of the disease.
Shortage of Canadian Rheumatologists Linked to Increase in Burnout
June 27, 2022
"The challenges of an existing rheumatologist workforce shortage, changing workforce demographics, and physician burnout have been compounded by the COVID-19 pandemic."
Patient-Reported Outcomes Positively Affected by Vaccine Availability During COVID-19 Pandemic
June 16, 2022
“The COVID-19 pandemic causes concern among patients with ARD due to increased risk of infection and heightened isolation from social distancing,” investigators explained.
Glucocorticoids Linked to Increase in COVID-19 Hospital Admissions in Patients with RA
May 26, 2022
COVID-19 has raised additional concerns for rheumatologists, especially regarding health care for patients with rheumatic diseases.
Ruxolitinib Treatment did not Benefit Patients With COVID-19
April 29, 2022
investigators initially theorized the drug may positively impact patients with COVID-19 treated with ruxolitinib.